APA (7th ed.) Citation

A, N., LD, K., M, R., N, S., M, G., P, H., . . . M, C. (2026). Reduced folate receptor alpha (FOLR1) protein expression in fallopian tubes from premenopausal women: Implications for the FOLR1 CDx assay for mirvetuximab-soravtansine therapy. The journal of pathology. Clinical research, 12(3), e70091. https://doi.org/10.1002/2056-4538.70091

Chicago Style (17th ed.) Citation

A, Nasdala, et al. "Reduced Folate Receptor Alpha (FOLR1) Protein Expression in Fallopian Tubes from Premenopausal Women: Implications for the FOLR1 CDx Assay for Mirvetuximab-soravtansine Therapy." The Journal of Pathology. Clinical Research 12, no. 3 (2026): e70091. https://doi.org/10.1002/2056-4538.70091.

MLA (9th ed.) Citation

A, Nasdala, et al. "Reduced Folate Receptor Alpha (FOLR1) Protein Expression in Fallopian Tubes from Premenopausal Women: Implications for the FOLR1 CDx Assay for Mirvetuximab-soravtansine Therapy." The Journal of Pathology. Clinical Research, vol. 12, no. 3, 2026, p. e70091, https://doi.org/10.1002/2056-4538.70091.